caselaw.findlaw.com/us-3rd-circuit/1313639.html

ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...

law.justia.com/cases/federal/appellate-courts/ca1/15-2232/15-2232-2017-05-02.html

May 8, 2017 ... Plaintiff appealed the district court's grant of summary judgment in favor of her former employer, AstraZeneca Pharmaceutical LP, on Plaintiff's ...

www.law360.com/cases/59e6216bb9a1b52a7e000001

Parties, docket activity and news coverage of federal case ATCHLEY et al v. ASTRAZENECA UK ... Defendant. ASTRAZENECA PHARMACEUTICALS LP ...

www.todaysworkplace.org/2005/03/15/for-once-an-ada-case-that-inspires-instead-of-depresses

Mar 15, 2005 ... Emory v. AstraZeneca, recently decided by the 3rd Circuit Court of Appeals, ... which essentially penalized him for all of his accomplishments in ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3405507

May 30, 2012 ... ... returning to specific antibody-based prophylaxis or therapy (Saylor et al., 2009) . ... Duplication of VH CDR3 loop sequences in the libraries, which is a measure of ...... were collected from AstraZeneca Pharmaceuticals LP, University of ..... Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4775982

All screen-positive cUTI pathogens were CTX-M-producing E. coli, except for one E. .... 144 and adenine 450 in the pabB gene, as previously described by Dhanji et al. (20). ..... of isolates were funded by AstraZeneca Pharmaceuticals (Waltham , MA). .... Jean SS, Ko WC, Xie Y, Pawar V, Zhang D, Prajapati G, Mendoza M, ...

www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/dermatologicandophthalmicdrugsadvisorycommittee/ucm511360.pdf

Jul 19, 2016 ... U.S. Agent for Valeant Pharmaceuticals Luxembourg S.a.r.l ...... sponsorship of the program was transferred to AstraZeneca, who ... Brodalumab met all primary endpoints (PASI 75 vs placebo, sPGA vs ...... Papp KA, Langley RG, Lebwohl M, et al. ...... Tallerova AV, Kovalenko LP, Durnev AD, Seredenin SB.

www.arcounties.org/site/assets/files/3397/2018-08-30_plaintiffs_omnibus_response.pdf

Aug 30, 2018 ... VS. Case No. 18CV-2018-268. PURDUE PHARMA, L.P., et al. ...... AstraZeneca Pharmaceuticals, L.P., 2009 Ark. 547, 351 S.W.3d 168 .